The Drugs Controller General of India (DCGI) has issued a public notice cautioning about the use of cosmetics in injectable forms. This alert, disseminated by the Central Drugs Standard Control Organisation (CDSCO), aims to inform manufacturers, importers, and consumers about the misleading claims and prohibited substances associated with such products.

According to the notice, dated May 21, 2026, cosmetics marketed as injectable preparations do not meet the legal definitions under the Drugs and Cosmetics Act of 1940. The regulator emphasised that no cosmetic should be used for injection, whether by consumers, professionals or aesthetic clinics.

The DCGI reiterated that cosmetic products should only be applied externally and strictly for their intended uses, which include cleansing, beautifying, and altering the appearance of the human body, as per the Cosmetics Rules of 2020.

Clarification on Cosmetic Regulations

The notice further clarified that cosmetics are not intended for therapeutic purposes. The use of cosmetics for treatment by both professionals and individuals is expressly prohibited, according to the notice. This regulation aims to ensure that the products remain within their defined scope and purpose.

The CDSCO cautioned against misleading labels and advertisements that could deceive consumers regarding the benefits and uses of cosmetic products. The provisions of labelling stipulate that no cosmetic product should convey false or misleading information to consumers.

In addition, the regulator stressed that individuals must not alter, deface, or obliterate any markings or inscriptions made by manufacturers on the labels or containers of cosmetics. This requirement aims to maintain transparency and accuracy in product information.

Prohibited Ingredients and Public Reporting

The public notice highlighted the importance of understanding the list of ingredients deemed “generally not recognised as safe” (GNRAS), which has been compiled by the Bureau of Indian Standards (BIS). The use of prohibited ingredients or misleading claims on labels is considered a serious violation of the Drugs and Cosmetics Act and associated rules.

Practices that involve the use of cosmetic products for treatment or their application through injection are specifically identified as violations under the Act. The notice stated, “The use of prohibited ingredients in cosmetic products and cosmetic treatment practices attract penalties.” Such measures are in place to protect consumers and ensure the safe use of cosmetics.

The CDSCO encouraged the public to report any violations, anomalies, or concerns directly to the regulatory authority via email and to the appropriate state licensing authorities. This initiative aims to facilitate greater compliance within the cosmetics industry and ensure consumer safety.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store –  https://apps.apple.com/in/app/newspin/id6746449540 

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share